Schizophrenia Treatment Flashcards

1
Q

Typically how long does drug treament for SCH take before symptoms are relieved? [1]

What is key to note about drug treatment and SCH? [1]

A

Improvement of symptoms takes 2-3 weeks

30% of patients do not respond to treatment - drug resistance.

·

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The drugs used to treat schizophrenia are [] receptor antagonists [1]

They can be divided into typical and atypical drug treatments; what are the difference between them?

A

The drugs used to treat schizophrenia are D2 (dopamine) receptor antagonists

Typical:’ are older and cause generalised dopamine receptor blockade.

Atypical: are more selective in their dopamine blockade and also block serotonin 5-HT2 receptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Atypical antipsychotic drugs target which receptor/s

D1 receptors
D2 receptors
D1 & D2 receptors
D1 & 5-HT2 receptors
D2 & 5-HT2 receptors

A

Atypical antipsychotic drugs target which receptor/s

D1 receptors
D2 receptors
D1 & D2 receptors
D1 & 5-HT2 receptors
D2 & 5-HT2 receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Name 5 typical antipyschotics

A

chlorpromazine, thioridazine,
fluphenazine, haloperidol, flupenthixol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why are typical anti-pyschotics commonly have poor compliance? [1]

A

The lack of selectivity of action of the drugs used, results in a wide range of unwanted effects, which decrease compliance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the effect of typical anti-physchotics on positive and negative symptoms [1]

A

Improve positive symptoms

Little/no efficacy on negative symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Name 6 atypical anti-psychotics used to treat SCH [6]

A

risperidone, olanzapine, clozapine, quetiapine, paliperidone, aripiprazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Atypical anti-psychotics target which receptors? [2]

A

Antagonists at:

  • D2 receptors
  • 5-HT2A receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Clozapine blocks [] receptors with high affinity
Aripiprazole is a partial [] at presynaptic D2 receptors but an [] at D2 postsynaptic receptors

A

Clozapine blocks D4 receptors with high affinity

Aripiprazole is a partial agonist at presynaptic D2 receptors but an antagonist at D2 postsynaptic receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Name 3 extrapyramidal effects that occur due to antipsychotic drugs. [3]

Why do these occur? [1]

A

Extrapyramidal effects (EPS):
* acute dystonias
* parkinsonism
* tardive dyskinesia

Approx. 60% D2 receptor occupancy required for
antipsychotic efficacy; if >80% D2 receptors are blocked, then potential for EPS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Explain why antipsychotic drugs may cause sexual dysfunction, galactorrhoea or amenorrhoea?

A

Block dopamine receptors; causes a rise in prolactin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

30% schizophrenic patients do not respond to treatment. Which drug would you provied for those who have drug resistance? [1]

A

Clozapine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Name a risk of clozapine treatment [2]

A

agranulocytosis: increases chance of infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which anti-psychotics can be adminstered by IM injections? [2]

A

fluphenazine decanoate

haloperidol decanoate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the difference in AEs between atypicals and typical anti-pyschotics

A

Atypicals
* Less EPS
* Less cardiac toxicity (QT segment prolongation)
* Less hyperprolactinaemia
* Weight gain
* Hyperglycaemia, diabetes
* Insulin resistance
* Dyslipidaemia
* Cardiovascular disease

Typicals:
EPS (dystonia, parkinsonism…)
Tardive dyskinesia
Weight gain
QT interval prolongation
Sudden death
Hyperprolactinaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Non-pharmacological approaches for SCH? [3]

A
  • Cognitive Behavioural Therapy
  • Cognitive remediation
  • Family therapy

These do not replace the pharmacological treatment

17
Q

Non-pharmacological approaches for SCH? [3]

A
  • Cognitive Behavioural Therapy
  • Cognitive remediation
  • Family therapy

These do not replace the pharmacological treatment

18
Q
A
19
Q

Describe the difference in AEs between atypicals and typical anti-pyschotics

A

Atypicals
* Less EPS
* Less cardiac toxicity (QT segment prolongation)
* Less hyperprolactinaemia
* Weight gain
* Hyperglycaemia, diabetes
* Insulin resistance
* Dyslipidaemia
* Cardiovascular disease

Typicals:
EPS (dystonia, parkinsonism…)
Tardive dyskinesia
Weight gain
QT interval prolongation
Sudden death
Hyperprolactinaemia

20
Q

Explain what tardive dyskinesia is and the length of the AE [2]

A

Involuntary movements of the lips, jaw, face; grimacing, constant chewing, tongue thrusting; rapid involuntary limb movements

typical antipsychotics,
taken for longer than a few months/years
In some patients it may be possible to overcome it

21
Q

Describe what neuroleptic malignant syndrome is a combination of [6]

A

Due to typical anti-psychotics

hyperpyrexia
muscle rigidity
tremor
confusion
autonomic instability

22
Q

Explain what future SCH drug targers are [3]

A

The NMDA glutamate receptor:

  • Decreased glutamatergic transmission in SCH- hypoglutamatergic state in cortex
  • May be possible to potentiate activity of glutamatergic receptors in future